Hung‐Chun Chen
Impact in
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
- Parathyroid Disorders and Treatments
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
Papers in
- Nephrology 147
- Chronic Kidney Disease and Diabetes 71
- Dialysis and Renal Disease Management 47
- Renal Diseases and Glomerulopathies 29
- Parathyroid Disorders and Treatments 13
-
- Cardiovascular Health and Disease Prevention 21
- Cardiovascular Function and Risk Factors 14
- Co-authors
- Shang‐Jyh Hwang (99 shared papers)Jer‐Ming Chang (103 shared papers)Jinn‐Yuh Guh (35 shared papers)Chi‐Chih Hung (48 shared papers)Szu‐Chia Chen (73 shared papers)Yi‐Wen Chiu (52 shared papers)Jer‐Chia Tsai (39 shared papers)Mei‐Chuan Kuo (44 shared papers)
- Journals
- PLoS ONE (20 papers)Scientific Reports (17 papers)American Journal of Kidney Diseases (11 papers)Clinical Journal of the American Society of Nephrology (10 papers)The American Journal of the Medical Sciences (10 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Hung‐Chun Chen
258 papers receiving 5.9k citations
Hung‐Chun Chen's Hit Papers
Peers
Comparison fields: 5 of 134
- Nephrology 2.8k
- Clinical Biochemistry 216
- Cardiology and Cardiovascular Medicine 873
- Hepatology 296
- Endocrinology, Diabetes and Metabolism 241
Countries citing papers authored by Hung‐Chun Chen
This map shows the geographic impact of Hung‐Chun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Chun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Chun Chen more than expected).
Fields of papers citing papers by Hung‐Chun Chen
This network shows the impact of papers produced by Hung‐Chun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Chun Chen. The network helps show where Hung‐Chun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung‐Chun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 261 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Hit paper breakdown → | 2023 | 195 |
| 2 | 2001 | 192 | |
| 3 | 2012 | 163 | |
| 4 | Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hit paper breakdown → | 2023 | 163 |
| 5 | 2014 | 133 | |
| 6 | 2012 | 120 | |
| 7 | 2014 | 102 | |
| 8 | 2011 | 98 | |
| 9 | 2013 | 98 | |
| 10 | 2010 | 94 | |
| 11 | 2011 | 88 | |
| 12 | 2013 | 84 | |
| 13 | 2000 | 79 | |
| 14 | 2008 | 79 | |
| 15 | 2004 | 76 | |
| 16 | 2000 | 70 | |
| 17 | 2002 | 70 | |
| 18 | 1999 | 69 | |
| 19 | 2014 | 66 | |
| 20 | 2007 | 62 |
About Hung‐Chun Chen
Hung‐Chun Chen is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Clinical Biochemistry, Physiology and Surgery, having authored 261 papers that have together received 6.2k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (71 papers), Dialysis and Renal Disease Management (47 papers), Renal Diseases and Glomerulopathies (29 papers), Cardiovascular Health and Disease Prevention (21 papers), Cardiovascular Function and Risk Factors (14 papers), Parathyroid Disorders and Treatments (13 papers), Peripheral Artery Disease Management (12 papers) and Advanced Glycation End Products research (8 papers). The work is most often cited by research in Nephrology (2.8k citations), Clinical Biochemistry (216 citations), Cardiology and Cardiovascular Medicine (873 citations), Hepatology (296 citations) and Endocrinology, Diabetes and Metabolism (241 citations). Hung‐Chun Chen has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Shang‐Jyh Hwang, Jer‐Ming Chang, Jinn‐Yuh Guh, Chi‐Chih Hung, Szu‐Chia Chen, Yi‐Wen Chiu, Jer‐Chia Tsai, Mei‐Chuan Kuo, Ming‐Yen Lin and Yung‐Hsiung Lai. Their work appears in journals such as PLoS ONE, Scientific Reports, American Journal of Kidney Diseases, Clinical Journal of the American Society of Nephrology and The American Journal of the Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.